There are several subtypes of breast cancer, including luminal A/B, HER2-positive, and triple-negative breast cancer (TNBC), depending on the expression of estrogen and progesterone receptors (ER, PR) and the human epidermal growth factor receptor-2 (HER2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.